Multidimensional NMR Studies of Immunosuppressant/Immunophilin Complexes

1993 ◽  
pp. 92-133
Author(s):  
Stephen W. Fesik ◽  
Placido Neri
1993 ◽  
pp. 215-219
Author(s):  
Stephen Fesik ◽  
Andrew Petros ◽  
Timothy Logan ◽  
Liping Yu ◽  
Robert Xu ◽  
...  

1997 ◽  
pp. 427-438 ◽  
Author(s):  
Jianjun Wang ◽  
Daisy Sahoo ◽  
Dean Schieve ◽  
Stéphane M. Gagné ◽  
Brian D. Sykes ◽  
...  

Author(s):  
Minghui Chai ◽  
Peter L. Rinaldi ◽  
Uraiwan Puapaiboon ◽  
Richard T. Taylor

2003 ◽  
Vol 36 (11) ◽  
pp. 4017-4028 ◽  
Author(s):  
Sangrama K. Sahoo ◽  
Tong Zhang ◽  
D. Venkat Reddy ◽  
Peter L. Rinaldi ◽  
Lester H. McIntosh ◽  
...  

2017 ◽  
Vol 398 (5-6) ◽  
pp. 577-588 ◽  
Author(s):  
Miriam Schöpel ◽  
Veena Nambiar Potheraveedu ◽  
Thuraya Al-Harthy ◽  
Raid Abdel-Jalil ◽  
Rolf Heumann ◽  
...  

Abstract Ras GTPases are key players in cellular signalling because they act as binary switches. These states manifest through toggling between an active (GTP-loaded) and an inactive (GDP-loaded) form. The hydrolysis and replenishing of GTP is controlled by two additional protein classes: GAP (GTPase-activating)- and GEF (Guanine nucleotide exchange factors)-proteins. The complex interplay of the proteins is known as the GTPase-cycle. Several point mutations of the Ras protein deregulate this cycle. Mutations in Ras are associated with up to one-third of human cancers. The three isoforms of Ras (H, N, K) exhibit high sequence similarity and mainly differ in a region called HVR (hypervariable region). The HVR governs the differential action and cellular distribution of the three isoforms. Rheb is a Ras-like GTPase that is conserved from yeast to mammals. Rheb is mainly involved in activation of cell growth through stimulation of mTORC1 activity. In this review, we summarise multidimensional NMR studies on Rheb and Ras carried out to characterise their structure-function relationship and explain how the activity of these small GTPases can be modulated by low molecular weight compounds. These might help to design GTPase-selective antagonists for treatment of cancer and brain disease.


1999 ◽  
Vol 96 (9/10) ◽  
pp. 1580-1584 ◽  
Author(s):  
I. Ségalas ◽  
S. Desjardins ◽  
H. Oulyadi ◽  
Y. Prigent ◽  
S. Tribouillard ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document